Navigation Links
Protein Essential for Kidney-to-Bladder Urine Transfer

Tests of a protein's role in the immune system have revealed a surprising connection to a kidney problem that occurs in approximately one percent of all live births//.

"This condition, which is known as functional obstruction, impairs the ureter’s ability to pump urine from the kidney to the bladder," says senior author Wojciech Swat, Ph.D., assistant professor of pathology and immunology. "If untreated, this leaves urine stuck in the kidney, which balloons and becomes at risk of failure."

Swat and colleagues found a similar condition in mice after the gene for a protein known as discs-large homolog 1 (DLGH1) was disabled.

When properly diagnosed, functional obstruction is normally treatable with surgery. But the study also produced tentative evidence that DLGH1 dysfunction may affect long-term risk of kidney failure even after successful treatment.

"We noted about one-third fewer nephrons in mice where this gene had been completely disabled," says co-senior author Jeffrey H. Miner, Ph.D., associate professor of medicine and of cell biology and physiology. "Nephrons are the filtering units of the kidney, and having too few of them can predispose to kidney failure later in life."

The findings, published in the online edition of Proceedings of the National Academy of Sciences, are the first to identify a factor that guides the orientation of smooth muscle cells, which surround the ureter and provide the pumping action that brings urine from the kidney to the bladder. Smooth muscles also play important roles in swallowing, digestion, reproduction, respiration, vision and other biological processes.

Swat and postdoctoral fellow Bénédicte Sammut, Ph.D., originally generated mice lacking DLGH1 to study the protein's role in a structure known as the immune synapse. As conceived by Swat's colleague Andrey Shaw, M.D., the Emil R. Unanue Professor of Immunobiology, the immune synapse is a specialized com
'"/>




Page: 1 2 3

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
Other Medicine News:Health News:Senators Lugar, Dodd, Boxer and Representatives Lee and McCollum Receive GAC Children's Champion Award 2Health News:Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 2Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 3Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 4Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 5Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 6Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 7Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 8Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 9Health News:Environmental Tectonics Corporation Announces Third Quarter and Year To Date Fiscal 2009 Results 10Health News:Most support Alzheimer's research based on family consent 2Health News:Most support Alzheimer's research based on family consent 3Health News:Physical activity, mood and serious mental illness 2
Breaking Medicine Technology:SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 2SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 1Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 2Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 4Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 5Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 6Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 7Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 8Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 9Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 10Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 11Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 12Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 13Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 14Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 15Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 16Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 17Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 18Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 19Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 20Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 21Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 22Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 23Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 24Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 25Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 26Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 27Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 28Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference 53829 1